Stoke Therapeutics Inc

-0.12 (-1.50%)
7:24:03 PM EDT: $7.95 +0.08 (+1.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)347.45M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3 Million
Adjusted EPS-$0.71
See more estimates
10-Day MA$8.53
50-Day MA$9.15
200-Day MA$11.97
See more pivots

Stoke Therapeutics Inc Stock, NASDAQ:STOK

45 Wiggins Avenue, Bedford, Massachusetts 01730
United States of America
Phone: +1.781.430.8200
Number of Employees: 117


Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.